| Molecular mobility of amorphous pharmaceutical solids below their glass transition temperatures BC Hancock, SL Shamblin, G Zografi Pharmaceutical research 12, 799-806, 1995 | 1184 | 1995 |
| Theoretical and practical approaches for prediction of drug–polymer miscibility and solubility PJ Marsac, SL Shamblin, LS Taylor Pharmaceutical research 23, 2417-2426, 2006 | 654 | 2006 |
| Characterization of the time scales of molecular motion in pharmaceutically important glasses SL Shamblin, X Tang, L Chang, BC Hancock, MJ Pikal The Journal of Physical Chemistry B 103 (20), 4113-4121, 1999 | 396 | 1999 |
| Mixing behavior of colyophilized binary systems SL Shamblin, LS Taylor, G Zografi Journal of pharmaceutical sciences 87 (6), 694-701, 1998 | 210 | 1998 |
| Interpretation of relaxation time constants for amorphous pharmaceutical systems SL Shamblin, BC Hancock, Y Dupuis, MJ Pikal Journal of pharmaceutical sciences 89 (3), 417-427, 2000 | 173 | 2000 |
| The effects of co-lyophilized polymeric additives on the glass transition temperature and crystallization of amorphous sucrose SL Shamblin, EY Huang, G Zografi Journal of thermal analysis 47, 1567-1579, 1996 | 171 | 1996 |
| Molecular mobility of amorphous pharmaceuticals determined using differential scanning calorimetry BC Hancock, SL Shamblin Thermochimica acta 380 (2), 95-107, 2001 | 169 | 2001 |
| Polymeric nanoparticles for increased oral bioavailability and rapid absorption using celecoxib as a model of a low-solubility, high-permeability drug M Morgen, C Bloom, R Beyerinck, A Bello, W Song, K Wilkinson, ... Pharmaceutical research 29, 427-440, 2012 | 160 | 2012 |
| Enthalpy relaxation in binary amorphous mixtures containing sucrose SL Shamblin, G Zografi Pharmaceutical research 15, 1828-1834, 1998 | 149 | 1998 |
| Improved protocol and data analysis for accelerated shelf-life estimation of solid dosage forms KC Waterman, AJ Carella, MJ Gumkowski, P Lukulay, BC MacDonald, ... Pharmaceutical research 24, 780-790, 2007 | 137 | 2007 |
| Discovery of the Hemifumarate and (α-l-Alanyloxy)methyl Ether as Prodrugs of an Antirheumatic Oxindole: Prodrugs for the Enolic OH Group RP Robinson, LA Reiter, WE Barth, AM Campeta, K Cooper, BJ Cronin, ... Journal of Medicinal Chemistry 39 (1), 10-18, 1996 | 126 | 1996 |
| The effects of absorbed water on the properties of amorphous mixtures containing sucrose SL Shamblin, G Zografi Pharmaceutical research 16, 1119-1124, 1999 | 125 | 1999 |
| Coupling between chemical reactivity and structural relaxation in pharmaceutical glasses SL Shamblin, BC Hancock, MJ Pikal Pharmaceutical research 23, 2254-2268, 2006 | 120 | 2006 |
| Water vapour sorption by pharmaceutical sugars BC Hancock, SL Shamblin Pharmaceutical Science & Technology Today 1 (8), 345-351, 1998 | 105 | 1998 |
| Polyamorphism: a pharmaceutical science perspective BC Hancock, EY Shalaev, SL Shamblin Journal of pharmacy and pharmacology 54 (8), 1151-1152, 2002 | 90 | 2002 |
| A pragmatic test of a simple calorimetric method for determining the fragility of some amorphous pharmaceutical materials BC Hancock, CR Dalton, MJ Pikal, SL Shamblin Pharmaceutical research 15, 762-767, 1998 | 81 | 1998 |
| Water vapor sorption by peptides, proteins and their formulations SL Shamblin, BC Hancock, G Zografi European Journal of Pharmaceutics and Biopharmaceutics 45 (3), 239-247, 1998 | 77 | 1998 |
| Crystalline mesophases: structure, mobility, and pharmaceutical properties E Shalaev, K Wu, S Shamblin, JF Krzyzaniak, M Descamps Advanced drug delivery reviews 100, 194-211, 2016 | 55 | 2016 |
| Direct Synthesis and Reactivity of Unsupported (. eta. 3-Oxaallyl) rhodium (I) Complexes GA Slough, R Hayashi, JR Ashbaugh, SL Shamblin, AM Aukamp Organometallics 13 (3), 890-898, 1994 | 53 | 1994 |
| Estimating the Critical Molecular Mobility Temperature (T^ sub K^) of Amorphous Pharmaceuticals BC Hancock, K Christensen, SL Shamblin Pharmaceutical research 15 (11), 1649, 1998 | 45 | 1998 |
